Home › NDC Lookup › RxCUI directory › RxCUI 731179

0.6 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe — RxCUI 731179

RxNorm drug concept · Semantic clinical drug
RxCUI 731179 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI731179
Official name0.6 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdarbepoetin alfa 0.3 MG per 0.6 ML Prefilled Syringe; darbepoetin alfa 300 MCG in 0.6 ML Prefilled Syringe; darbepoetin alfa 300 MCG per 0.6 ML Prefilled Syringe
FDA products mapped14
Package NDCs mapped15
Reported Medicaid activity (SDUD)47,924 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darbepoetin Alfa Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Aranesp helps your body make more red blood cells. When your kidneys aren't working well, or when chemotherapy is suppressing your bone marrow, your body can't produce enough red b...
  • What exactly is Aranesp doing for me — why do I need it?
  • It takes some patience — hemoglobin levels typically don't start rising until about 2 to 6 weeks into treatment. You won't feel the difference right away after the first shot. Your...
  • How soon will I start to feel better after my first injection?
📖 Read our full Darbepoetin Alfa Injection guide →

🕸️ Concept Web — How 0.6 ML darbepoetin alfa 0.5 MG/ML Prefilled Syri... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.6 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe RxCUI 731179

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Darbepoetin alfa 283838
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aranesp 337045
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Darbepoetin alfa Prefilled Syringe 730043
    • Darbepoetin alfa Injectable Product 1157180
    • Darbepoetin alfa Prefilled Syringe [Aranesp] 730045
    • Aranesp Injectable Product 1170094
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Darbepoetin alfa 0.5 MG/ML SCDC · 405800
  • Darbepoetin alfa Prefilled Syringe SCDF · 730043
  • Darbepoetin alfa Injectable Product SCDG · 1157180

Brand-Name Concepts

📦 FDA Products & Package NDCs

14 products · 15 package NDCs
15 package NDCs map to RxCUI 731179 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55513-0002-04 4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-002-04) / 1 mL in 1... ARANESP Amgen, Inc 2006-09-11
55513-0003-04 4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-003-04) / 1 mL in 1... ARANESP Amgen, Inc 2006-09-11
55513-0004-04 4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-004-04) / 1 mL in 1... ARANESP Amgen, Inc 2006-09-11
55513-0005-04 4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-005-04) / 1 mL in 1... ARANESP Amgen, Inc 2006-09-11
55513-0006-01 1 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-006-01) / 1 mL in 1... ARANESP Amgen, Inc 2006-09-11
55513-0006-21 1 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-006-21) / 1 mL in 1... ARANESP Amgen, Inc 2025-07-01
55513-0021-04 1 BLISTER PACK in 1 PACKAGE (55513-021-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-14
55513-0023-04 1 BLISTER PACK in 1 PACKAGE (55513-023-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-14
55513-0025-04 1 BLISTER PACK in 1 PACKAGE (55513-025-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-14
55513-0027-04 1 BLISTER PACK in 1 PACKAGE (55513-027-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-09-11
55513-0028-01 1 BLISTER PACK in 1 PACKAGE (55513-028-01) / 1 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-14
55513-0032-01 1 BLISTER PACK in 1 PACKAGE (55513-032-01) / 1 SYRINGE in 1... ARANESP Amgen, Inc 2006-06-07
55513-0057-04 1 BLISTER PACK in 1 PACKAGE (55513-057-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-26
55513-0098-04 1 BLISTER PACK in 1 PACKAGE (55513-098-04) / 4 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-26
55513-0111-01 1 BLISTER PACK in 1 PACKAGE (55513-111-01) / 1 SYRINGE in 1... ARANESP Amgen, Inc 2006-08-14
Observed labelers: Amgen, Inc (15) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0881 Darbepoetin alfa, non-esrd 14 CMS
J0882 Darbepoetin alfa, esrd use 14 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.